Evaluating the clinical utility of newly-developed Ocular Surface Tribometer.

Evaluating the clinical utility of newly-developed Ocular Surface Tribometer on ocular surface disease.

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCTs062180056

Enrollment

Registered

2019-03-18

Start date

2015-04-14

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dry eye disease, Lid-wiper epitheliopathy and Superior limbic keratoconjunctivitis

Interventions

Normal volunteers and patients of ocular surface disease (dry eye disease, Lid-wiper epitheliopathy or superior limbic keratoconjunctivitis) were measured the frictional coeffcient of ocular surface

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Normal subjects and patients of ocular surface disease (Lid-wiper epitheliopathy, dry eye disease, superior limbic keratoconjunctivitis, etc.) The eligible subjects were >=20 years and written informed consent.

Exclusion criteria

Exclusion criteria: 1.Active ocular infection 2.Corneal ulcer 3.Allergy of topical anesthesia 4.Pregnant, unwilling to practice contraception during the study,or lactating female

Design outcomes

Primary

Measure	Time frame
Frictional Coefficient, Reproducibility	—

Secondary

Measure	Time frame
adverse events	—

Contacts

Public ContactYuri Sakane

Ehime university hospital

y-sakane@m.ehime-u.ac.jp+81-89-960-5361

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026